ArticleJournal of nanobiotechnology2021

Administration route governs the therapeutic efficacy, biodistribution and macrophage targeting of anti-inflammatory nanoparticles in the lung.

Lu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.